On statistical reanalysis, the EORTC trial is a positive trial for adjuvant chemoradiation in pancreatic cancer
- PMID: 16858208
- PMCID: PMC1602155
- DOI: 10.1097/01.sla.0000229980.81505.44
On statistical reanalysis, the EORTC trial is a positive trial for adjuvant chemoradiation in pancreatic cancer
Comment on
-
Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group.Ann Surg. 1999 Dec;230(6):776-82; discussion 782-4. doi: 10.1097/00000658-199912000-00006. Ann Surg. 1999. PMID: 10615932 Free PMC article. Clinical Trial.
References
-
- Kalser MH, Ellenberg SS. Pancreatic cancer: adjuvant combined radiation and chemotherapy following curative resection. Arch Surg. 1985;120:899–903. - PubMed
-
- Gastrointestinal Tumor Study Group. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer. 1987;59:2006–2010. - PubMed
-
- Green S, Benedetti J, Crowley J, eds. Clinical Trials in Oncology (Interdisciplinary Statistics). Boca Raton, FL: Chapman & Hall/CRC Press, 1997.
-
- Radiation Therapy Oncology Group. RTOG 97-04. (accessible at http://rtog.org/members/protocols/97-04/97-04.pdf).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
